EnsiliTech

📍 Bristol, United Kingdom🗓 Founded 2022👥 17 employees💰 Last funded Sep 2025
Biotechnology Research🌐 ensilitech.com
Website LinkedIn
Our patented novel Ensilication technology uses silica to create an individually tailored protective nanoshell around vaccines, antibodies and enzymes to prevent degradation, which can lead to spoilage. Once applied, the material can be stored and transported without the need for cold chain infrastructure, improving global access to medicines and reducing wastage and emissions across the pharmaceutical supply chain. Ensilication preserves the integrity of a wide variety of biomolecules and proteins, not only protecting against environmental degradation, but also making possible the development of more convenient administration such as subcutaneous and oral delivery for both humans and animals. We are actively looking for partners to work with us in developing ensilicated products, free from cold chain dependence. Please don’t hesitate to contact us if you’re interested in finding out more about us, and how our technology may benefit your products.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in EnsiliTech?
EnsiliTech has 1 investors on record on gritt.io, 1 mid-stage.
When did EnsiliTech last raise funding?
The most recent investment in EnsiliTech recorded on gritt.io was in September 2025.
When was EnsiliTech founded?
EnsiliTech was founded in 2022.
What industry is EnsiliTech in?
EnsiliTech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EnsiliTech based?
EnsiliTech is headquartered in Bristol, United Kingdom.